Eastgate Biotech Corp. (ETBI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY, UT 84109 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 6799 - Investors, Not Elsewhere Classified (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2017 MRQ | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 19 | 286 | 0 | 100 | ||||
| Cash and cash equivalents | 19 | 286 | 0 | 100 | ||||
| Receivables | 80 | 53 | ||||||
| Other undisclosed current assets | 15 | 5 | ||||||
| Total current assets: | 114 | 340 | 0 | 105 | ||||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 184 | 143 | 71 | |||||
| Total noncurrent assets: | 184 | 143 | 71 | |||||
| TOTAL ASSETS: | 298 | 483 | 72 | 105 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 280 | 361 | 299 | |||||
| Interest and dividends payable | 433 | 293 | 183 | |||||
| Taxes payable | 108 | |||||||
| Other undisclosed accounts payable and accrued liabilities | (262) | 68 | 116 | |||||
| Debt | 10 | 8 | ||||||
| Deferred revenue and credits | 93 | 26 | 4 | |||||
| Due to related parties | 2,096 | 732 | 389 | |||||
| Other undisclosed current liabilities | 2,099 | 1,601 | 1,189 | 2,399 | 714 | |||
| Total current liabilities: | 4,578 | 2,729 | 1,881 | 2,399 | 714 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation, including: | 40 | 50 | ||||||
| Other undisclosed long-term debt and lease obligation | 40 | 50 | ||||||
| Total noncurrent liabilities: | 40 | 50 | ||||||
| Total liabilities: | 4,618 | 2,779 | 1,881 | 2,399 | 714 | |||
| Equity | ||||||||
| Equity, attributable to parent, including: | (4,618) | (2,481) | (1,398) | (2,327) | (609) | |||
| Common stock | 3 | 3 | 0 | |||||
| Additional paid in capital | 9,970 | 9,138 | 5,958 | 135 | 135 | |||
| Accumulated other comprehensive income | 40 | 32 | 15 | 0 | ||||
| Accumulated deficit | (14,631) | (11,654) | (744) | |||||
| Other undisclosed equity, attributable to parent | (7,371) | (2,463) | 0 | |||||
| Total equity: | (4,618) | (2,481) | (1,398) | (2,327) | (609) | |||
| TOTAL LIABILITIES AND EQUITY: | 298 | 483 | 72 | 105 | ||||
Income Statement (P&L) ($ in thousands)
| 9/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 132 | ||||||
| Cost of revenue (Cost of Goods and Services Sold) | (19) | ||||||
| Gross profit: | 113 | ||||||
| Operating expenses | (2,634) | (4,284) | (4,819) | (1,656) | (606) | ||
| Other operating expense, net (Other Expenses) | (64) | (17) | |||||
| Operating loss: | (2,634) | (4,171) | (4,819) | (1,720) | (623) | ||
| Nonoperating expense | (344) | (110) | (89) | ||||
| Interest and debt expense | (160) | (110) | (89) | 64 | 17 | ||
| Loss from continuing operations before equity method investments, income taxes: | (3,137) | (4,391) | (4,997) | (1,656) | (606) | ||
| Other undisclosed income from continuing operations before income taxes | 160 | 110 | 89 | ||||
| Loss from continuing operations: | (2,977) | (4,281) | (4,908) | (1,656) | (606) | ||
| Loss before gain (loss) on sale of properties: | (2,977) | (4,281) | (4,908) | (1,656) | (606) | ||
| Other undisclosed net loss | (64) | ||||||
| Net loss: | (2,977) | (4,281) | (4,908) | (1,720) | (606) | ||
| Other undisclosed net loss attributable to parent | (17) | ||||||
| Net loss available to common stockholders, diluted: | (2,977) | (4,281) | (4,908) | (1,720) | (623) | ||
Comprehensive Income ($ in thousands)
| 9/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (2,977) | (4,281) | (4,908) | (1,720) | (606) | ||
| Other comprehensive income | 0 | ||||||
| Comprehensive loss: | (2,977) | (4,281) | (4,908) | (1,720) | (606) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 8 | 17 | 15 | ||||
| Comprehensive loss, net of tax, attributable to parent: | (2,970) | (4,265) | (4,893) | (1,720) | (606) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.